SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-22-000352
Filing Date
2022-01-07
Accepted
2022-01-07 21:17:11
Documents
2
Period of Report
2022-01-06

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 28124
2 POA2021 estockpoa21.txt EX-24 3345
  Complete submission text file 0001562180-22-000352.txt   32843
Mailing Address 215 CHURCH STREET NEW HAVEN CT 06510
Business Address 215 CHURCH STREET NEW HAVEN CT 06510 203-404-0410
Biohaven Pharmaceutical Holding Co Ltd. (Issuer) CIK: 0001689813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 215 CHURCH STREET NEW HAVEN CT 06510
Business Address (203) 404-0410
Stock Elyse (Reporting) CIK: 0001785732 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38080 | Film No.: 22519447